|1.||Handreke, Kerstin: 1 article (05/2002)|
|2.||Krause, Werner: 1 article (05/2002)|
|3.||Schuhmann-Giampieri, G: 1 article (05/2002)|
|4.||Rupp, K: 1 article (05/2002)|
|5.||Mahler, M: 1 article (08/2001)|
|6.||Kaufmann, J: 1 article (08/2001)|
|7.||Hanke, B: 1 article (08/2001)|
|8.||Hamm, B: 1 article (08/2001)|
|9.||Rogalla, P: 1 article (08/2001)|
|10.||Milius, W: 1 article (08/2001)|
05/01/2002 - "To investigate the efficacy of the new liver-specific x-ray contrast agent, Dy-EOB-DTPA, in rabbits with VX2 liver tumors by spiral computed tomography (CT) in comparison to iopromide. "
05/01/2002 - "Efficacy of the iodine-free computed tomography liver contrast agent, Dy-EOB-DTPA, in comparison with a conventional iodinated agent in normal and in tumor-bearing rabbits."
05/01/2002 - "Dy-EOB-DTPA injection at a dose of 0.5 mmol/kg resulted in a long-lasting detectability of 93% of all implanted tumors versus 79% found with iopromide."
05/01/2002 - "In plain CT, seven tumors (50%) were found (P < 0.01 vs iopromide and Dy-EOB-DTPA). "
05/01/2002 - "Sixty-five percent of the tumors were below 10 mm. Dy-EOB-DTPA was able to detect 13 tumors (93%), iopromide 11 (79%) both in the arterial and in the portal-venous phase. "
|2.||Neoplasm Metastasis (Metastasis)
08/01/2001 - "To investigate the tolerance and pharmacokinetics of the new liver-specific x-ray contrast agent Dy-EOB-DTPA [(4S)-4-(4-ethoxybenzyl)-3,6,9-tris(carboxylatomethyl)-3,6,9-triazaundecanedioic acid, dysprosium (Dy) complex, disodium salt] in healthy volunteers and to obtain preliminary imaging data by abdominal spiral computed tomography (CT) in tumor patients with liver metastases. "
08/01/2001 - "Two patients with suspected liver metastases first received 120 mL of iopromide (300 mg iodine/mL; approximately 0.6 mmol/kg) and, 24 or 72 hours later, Dy-EOB-DTPA at a dose of 0.25 mmol/kg. Computed tomography images were obtained 50 seconds after iopromide administration and before and 90 minutes after Dy-EOB-DTPA administration. "
08/01/2001 - "In the tumor patients, CT scanning after Dy-EOB-DTPA injection increased the number of detected metastases from 27 (plain scan) to 40 (iopromide) and then to 41 (Dy-EOB-DTPA) in patient No. 1 and from 1 (plain scan and iopromide) to 3 (Dy-EOB-DTPA) in patient No. 2. Dysprosium-EOB-DTPA was shown to be a well-tolerated liver-specific contrast agent. "
|4.||Pentetic Acid (DTPA)